MH
Morziul Haque
About Morziul Haque
Data last updated:
Morziul Haque is a Designated Partner at Famor Clinical Research Solutions Llp (since 2026) and Designated Partner at Pharmivon Media Llp (since 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 16 Jul 2026 | 2026 | Active | ||
 Pharmivon Media Llp ACU-0081 | Designated Partner | 06 Jan 2026 | 2026 | Active |
Board colleagues of Morziul Haque
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jabar Assan Farish Ahammed | 11827685 | Famor Clinical Research Solutions Llp | Designated Partner |
| Abdul Rahman | 11467193 | Pharmivon Media Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Morziul Haque
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Morziul Haque
Morziul Haque currently holds 2 directorships: Famor Clinical Research Solutions Llp (Designated Partner, since 16 Jul 2026); Pharmivon Media Llp (Designated Partner, since 06 Jan 2026).
Morziul Haque was first appointed on 06 Jan 2026 as Designated Partner at Pharmivon Media Llp.
The current boards of Morziul Haque's companies include Jabar Assan Farish Ahammed (Famor Clinical Research Solutions Llp), Abdul Rahman (Pharmivon Media Llp).